Chambre d'inhalation TipsHaler

TipsHaler® valved holding chamber: for inhaled treatment of asthma and respiratory diseases.

The TipsHaler® valved holding chamber was specially developed to optimize inhaled corticosteroids alone or in combination treatments. Thanks to its technical specifications, it optimizes the pulmonary distribution of these inhaled drugs. It was designed in Normandy through OptimHal®’s Research team and is fully manufactured in France.

La chambre d'inhalation TipsHaler®

Technical device

Certified processes

Convenient and unbreakable

Planet friendly sustainable

TipsHaler® valved holding chamber : a technical device with a proven efficiency
A technical device to respect the medical treatment specifications

TipsHaler® valved holding chamber is a class 1 or a class 2 medical device according to the regulations of the countries where it is available.

It was developed by Laboratoire OptimHal®’s research department, which is ISO 13485: 2016 and ISO 9001: 2015 certified. TipsHaler® is manufactured in an ISO 13485: 2016 and ISO 9001: 2015 certified French factory.

Proven efficiency

La chambre d'inhalation TipsHaler® par OptimHal®

Several studies have been carried out to assess the efficiency of the TipsHaler® valved holding chamber with most of the available metered dose inhalers delivered drugs.

  • The TipsHaler® valved holding chamber significantly reduces drug sendiment in the throat and in the trachea. Which help reducing potential local side effects.
  • The TipsHaler® valved holding chamber increases the drug deposition in the “deep” lung, where the drug is needed.

TipsHaler® is an optimized valved holding chamber for inhaled corticosteroids

IsoBreath® : An innovative patented valve system

La valve Isobreath®

The Isobreath® inspiratory valve (international patents apply is a conical anti-reversal valve which provides a progressive calibrated resistance to inspiration to promote deep pulmonary distribution of fine particles and to minimize their impaction into the oropharyngeal cavity.

A conical valve designed to modulate the respiratory flow

Decreasing the inhalation speed rate of the particles improves the deep pulmonary deposition of the drug.

Thanks to its distinctive shape, the Isobreath® valve is designed to avoid any resistance to the toddlers’ low flow thanks to its slight opening at rest and is designed to progressively oppose significant resistance to high inspiratory flows.

The expiratory valve: a visual control

TipsHaler® is equipped with a visible and removable exhalation expiratory valve, that allows visual control of the drug inhalation. This valve prevents the inhalation of outside air and decreases minimises the number of breaths required to inhale the drug medicine. It is essential for effective use, especially for very young user.

Les valves de la chambre d'inhalation TipsHaler®

An optimized size, shape and material for an « OptimHal® » drug delivery in the pulmonary tree

TipsHaler® capte et bloque les plus grosses particules

The TipsHaler® valved holding chamber offers optimised shape and material for better selection of fine particles and better pulmonary distribution of the medication.

The bowl shape at the front of TipsHaler® combined with a better control of the electrostatic charge of the material, allows to capture and block in the chamber the larger particles that would have impact the mouth and throat. These particles can potentially cause side effects and have no therapeutic effect. These characteristics therefore allow for a better selection of the finest particles that will go to treat the deep lung.

OrHal® : a new innovative partitioned inhalation mask

OrHal®, the first pediatric and adult partitioned inhalation mask was developed to optimized inhaled treatments.

From 12 months old, the nose gradually becomes efficient as a filter against the inhalation of foreign particles thanks to the ciliary system and nasal mucus. To ensure a good treatment the efficiency of the treatment, it is essential that the inhalation is done through the mouth. OrHal® is the first inhalation mask designed with an isolated cavity for the mouth of adults and children over 1 year old.

TipsHaler® avec masque OrHal® pédiatrique 

Improve/Favor oral inhalation for children over 1 year

Thanks to its flexible and airtight partition between the nose and the mouth, OrHal® avoids nasal inhalation and favors oral inhalation. It allows better pulmonary deposition of the drug by preventing it from being trapped by the nose.

Optimizes treatment intake

The partition of the OrHal® mask reduces the dead volume* of the mask and allows a better use of the aerosol in the inhalation chamber.

Facilitates treatment administration

Thanks to its flexibility and transparency, OrHal® facilitates the positioning on the face. A Proper positioning improves the sealing and limits the leak on the face, which limits the inhalation of air without medication.  

* The dead volume of the inhalation chamber is the drug-free air between the inspiratory valve and the face that is inhaled before the medication.

TipsHaler® : the certified valved holding chamber

In Europe, inhalation chambers are class 1 medical devices for which regulatory requirements are reduced.  A simple declaration from the manufacturer makes it possible to market an inhalation chamber.

However, in some areas (such as Japan or North America), the requirements for this type of device are significantly more restrictive. To be able to commercialize TipsHaler® in these countries, the Laboratoire OptimHal® included all of the research, design and manufacturing processes of its inhalation chambers within the scope of its ISO 13485: 2016 certification.

This certification is provided by a notified body, independent and approved by health authorities organization, in particular in Europe and North America. It guarantees that during all the research, design, manufacturing and distribution processes:

TipsHaler, chambre d'inhalation certifiée

  • All international standards for valved holding chambers are respected
  • The medical utility of the device has been proven by studies and tests.
  • The materials used proved their biocompatibility and their lack of interaction with the drugs administered.
  • The information provided are duly justified and therefore sincere

Convenient and unbreakable

The TipsHaler® valved holding chamber is designed to simplify and improve the intake of inhaled metered dose inhaler treatments and to adapt to individual needs. Its various masks and its mouthpiece, its easy to maintain and the absence of toxic substances make it a convenient, useful and safe valved holding chamber.

Unbreakable

The TipsHaler® valved holding chamber is made of polypropylene, thermoplastic-elastomer and silicone. Thanks to these materials, the TipsHaler® valved holding chamber is a solid device.

The ergonomic TipsHaler® valved holding chamber suitable for everyone

Ergonomic, comfortable with a reduced dead volume, the TipsHaler® masks guarantee the air tightness with the face to prevent from leaking. Therefore, they improve the intake of the treatments.

TipsHaler® valved holding chamber is available in several versions depending on the age and the needs of the patient.

 TipsHaler® infant chamber

Infant mask

From  0 to 12 months-old

TipsHaler® pediatric inhalation chamber

 OrHal® pediatric mask

12 months-old to 6 years-old

Masque pédiatrique OrHal® pour chambre d'inhalation

TipsHaler® inhalation chamber

Mouthpiece

Over 6 years-old

La chambre d'inhalation TipsHaler®, sans masque

TipsHaler® adult inhalation chamber

OrHal® adult mask

Adult

Masque adulte OrHal® pour chambre d'inhalation

Visible expiratory valve

 La valve visuelle

When administering inhaled metered dose inhaler treatments to young children, it is often not easy to see whether the child has taken its medication correctly.

The TipsHaler® valved holding chamber valve system allows you to visualize the movements of the exhalation valve while taking treatments. This mobile and visual valve makes it possible to check the child’s respiratory cycles inside the valved holding chamber and thus ensure that the treatment is taken properly.

TipsHaler®, easy to take apart for an optimal hygiene

TipsHaler®, facile à démonter

Maintaining your inhalation chamber is essential to ensure proper delivery of treatment on a daily basis.

For an optimal hygiene, the TipsHaler® valved holding chamber is completely removable, and therefore fully washable. It enables to eliminate the deposit of drugs that are accumulating during the intake of treatment, and limits the growth of bacteria inside the valved holding chamber.

Compatible with most of metered dose inhalers 

TipsHaler® s'adapte à la majorité des aérosol-doseurs

Due to the wide variety of metered dose inhaler forms, an valved holding chamber must be adaptable to most treatments. Thanks to its flexible rear adapter, the TipsHaler® valved holding chamber is compatible with the majority of metered dose inhalers.

TipsHaler® was specifically designed for base treatments but is also suitable for other treatments as shown by studies carried out with numerous drugs. This asset makes it possible to use a single valved holding chamber when the doctor prescribes more than one metered-dose inhaler treatment.

The planet friendly valved holding chamber

From a sustainable perspective, our teams are committed to making their technical and economic choices that respect the planet our planet. For TipsHaler®, this translates into a:

Polypropylene tank

The balloon shaped tank of the valved holding chamber is made of polypropylene. It is actually one of the most easily recyclable polymers. To ensure recycling, the patient have to put the used valved holding chamber according to the waste sorting, in the plastic recycling bin.

100% recyclable packaging

TipsHaler® est 100% recyclable

The new packaging of the TipsHaler® valved holding chamber is now made of four times less plastic than it used to be (7g versus 31g).

This packaging is 100% recyclable, 50% of which is already recycled and complies with the latest international standards for packaging medical devices.

Respectful of your health

La chambre d'inhalation TipsHaler® est respectueuse de votre santé

In order to ensure better use and to respect your health, the TipsHaler® valved holding chamber is a guaranteed medical device phthalates free, Bisphenol A free, latex free and heavy metals free. All the materials used for the valved holding chamber are non-toxic and healthy polymers which biocompatibility is certified ISO 10993-5 and ISO 10993-10.

How to use the TipsHaler® valved holding chamber ?

Discover the right gestures in this video.

The TipsHaler® valved holding chamber is distributed in France by the laboratory PediAct

Pediact et OptimHal®

38-42 rue Gallieni 92600 ASNIERES SUR SEINE
info@pediact.com – Tél : 01.76.21.61.20 – Service client : 01.76.21.61.24

Barcodes to communicate to your pharmacist :

TipsHaler® Valved holding chamber with infant mask: 3760079800822

TipsHaler® Valved holding chamber with OrHal paediatric mask: 3760079800815

TipsHaler® Valved holding chamber without mask: 3760079800808

TipsHaler® Valved holding chamber with adult mask: 3760079800976

The TipsHaler® valved holding chamber is distributed in several countries. It is available on stock or on request in all pharmacies. For more information, please contact us.

Due to registration delays in some countries, this TipsHaler® valved holding chamber is still available

Scientifics publications   

Comparaison in vitro de différents dispositifs pour la déposition médicamenteuse en néonatologie : chambre d’inhalation ou nébulisation pneumatique ?

CPAP 2021 : B. Hervieu, M. Eckes, L. Fontaine, N. Duval, T. Porée.


Etude sur l’effet d’une inhalation sans valve inspiratoire et sans masque facial pour les nouveau-nés sur l’administration de médicaments.

DDL 2021 : M. Eckes, B. Hervieu, L. Fontaine, T. Porée.


Etude sur les chambres d’inhalation en néonatologie : Intérêt d’un dispositif sans espace mort et durée de maintien du masque facial pour une inhalation optimale des corticostéroïdes.

EAP 2021 : B. Hervieu, L. Fontaine, M. Eckes, T. Porée.


Étude sur l’amélioration de la déposition pulmonaire de QVAR grâce à une chambre d’inhalation innovante et intuitive permettant un meilleur tri des particules.

ERS 2020 : B. Demouveaux, A. Vanlaeys, T. Porée.


Étude sur le développement et l’évaluation in vitro d’un nouveau prototype de chambre d’inhalation sans volume mort et effet du nombre de cycles respiratoires sur la dose délivrée aux nouveau-nés.

ATS 2020 : T.Porée, B. Demouveaux, B. Hervieux, M. Eckes.


Étude sur la validation de la méthode de chromatographie en phase liquide à haute performance par couplage ionique pour la quantification simultanée du fumarate de formotérol (FF), du dipropionate de béclométhasone (BDP) et du bromure de glycopyrronium (GB).

ISAM 2019 : J. Kazmierczak, M. Eckes, E. Curran, T. Porée.


Étude sur les chambres d’inhalation et néonatalité : influence in vitro du nombre de cycles respiratoires sur la dose de médicaments déposée. Comparaison d’une chambre prototype à deux chambres de référence.

CPAP 2019 : B. Hervieu, M. Eckes, T. Porée.


Étude sur l’nalyse fonctionnelle de plusieurs valves inspiratoires de chambre d’inhalation.

CIPP 2019 : E.Curran, T. Porée.


Étude sur l’analyse de l’impact d’un débitmètre à sonde Annubar (DigitHal®) inséré dans une chambre d’inhalation à retenue valvée.

CIPP 2019 : E. Curran, J.Kazmierczak, T. Porée.


Étude sur les simulations de dynamique des fluides numériques et tests in vitro sur l’importance des valves expiratoires pour les chambres d’inhalation.

ISAM 2017 : E. Furon, F. Vanel, T. Porée, J-C. Dubus.


Étude sur la caractérisation in vitro de l’ajout d’une cloison séparant la bouche du nez dans un masque facial pédiatrique.

CIPP 2017 : E.Furon, T. Porée.


Étude sur la validation in vitro de l’utilisation d’une chambre d’inhalation aves des formulations contenant des particules extrafines.

ERS 2016 : E. Furon, Phd & T. Porée.


Étude sur la comparaison du dépôt d’aérosol avec l’administration dans différentes phases du cycle respiratoire.

CIPP 2015 : N.Boukhettala, T. Porée, P.Diot, L. Vecellio.


Étude sur l’interaction entre le médicament et les matériaux composants d’une chambre d’inhalation

ATS 2014 : N. Boukhettala, T. Porée.


Étude sur les performances in vitro d’une chambre d’inhalation à retenue valvée avec des corticoïdes inhalés.

RDD 2014 : N. Boukhettala, T. Porée, L. Nadal-Desbarats.


Étude sur les performances in vitro d’une chambre d’inhalation à retenue valvée avec des corticoïdes inhalés.

WISC 2014 : N. Boukhettala, T. Porée, P. Diot, L. Vecellio.


Étude sur la comparaison des performances in vitro de deux chambres d’inhalation à retenue valvée.

CIPP 2013 : N. Boukhettala, P. Diot, L. Vecellio, T. Porée.


Étude sur la comparaison du dépôt d’aérosol avec l’administration dans différentes phases du cycle respiratoire.

RDD 2012 : N. Boukhettala, P. Diot, T. Porée, L. Vecellio.

The trademarks TipsHaler®, OrHal® and IsoBreath® belongs to OptimHal-ProtecSom SAS.